Glaukos (GKOS) EBITDA (2014 - 2026)
Glaukos (GKOS) posted quarterly EBITDA of -$17.3 million for Q2 2026, up 23.9% year-over-year from -$13.9 million in Q2 2025, and up 13.04% quarter-over-quarter from -$19.9 million in Q1 2026.
Glaukos (GKOS) EBITDA (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported EBITDA for 13 consecutive years, with -$17.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA rose 23.9% year-over-year to -$17.3 million; the TTM figure through Jun 2026 stood at -$193.4 million (down 99.97% YoY), while the FY2025 annual figure was -$199.6 million, down 63.12% from the prior year.
- EBITDA grew to -$17.3 million in Q2 2026 per GKOS's latest filing, from -$19.9 million in the prior quarter.
- Across five years, EBITDA topped out at $9.8 million in Q1 2022 and bottomed at -$139.9 million in Q4 2025.
- Historically, EBITDA has averaged -$31.7 million across 5 years, with a median of -$28.3 million in 2023.
- Annual changes were most pronounced in 2022 — EBITDA jumped 182.95% — and 2023, when it sank 436.94%.
- Glaukos' EBITDA stood at -$33.7 million in 2022, then retreated by 14.49% to -$38.6 million in 2023, then increased by 25.78% to -$28.7 million in 2024, then slumped by 387.92% to -$139.9 million in 2025, then soared by 87.65% to -$17.3 million in 2026.
- Business Quant data shows GKOS's EBITDA at -$17.3 million in Q2 2026, -$19.9 million in Q1 2026, and -$139.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Glaukos | 10.91 Bn | 10.80 Bn | 151.59 Mn | -17.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.27 Mn |
| Mar 31, 2026 | -19.86 Mn |
| Dec 31, 2025 | -139.87 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Jun 30, 2025 | -22.69 Mn |
| Mar 31, 2025 | -20.68 Mn |
| Dec 31, 2024 | -28.67 Mn |
| Sep 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -29.97 Mn |
| Mar 31, 2024 | -39.07 Mn |
| Dec 31, 2023 | -38.62 Mn |
| Sep 30, 2023 | -28.01 Mn |
| Jun 30, 2023 | -29.08 Mn |
| Mar 31, 2023 | -32.99 Mn |
| Dec 31, 2022 | -33.73 Mn |
| Sep 30, 2022 | -21.61 Mn |
| Jun 30, 2022 | -36.76 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | -17.87 Mn |
| Sep 30, 2021 | 11.02 Mn |